PATENT CLAIM ANALYSIS

Application Number: 15973645
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["514", "179000"]

Abstract:
The present invention relates to novel neurosteroids, especially derivatives of allopregnanolone and of epiallopregnanolone of formula (I) and the uses thereof as medicament for the treatment of neuropathologies, in particular neuropathies induced by the chemotherapy of a cancer. These molecules according to the invention have both preventative and curative effects. The neurosteroids according to the invention may also be of use in the treatment of neurodegenerative disorders, in particular for preventing neuronal cell death. They may thus be used as neuroprotectants and/or as an agent that stimulates neuronal proliferation.

Claim (Index 11):
The derivative according to  claim 8 , wherein the neuropathology is linked to an allodynia or hyperalgesia.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 93.0
- Lexical Diversity: 1.55556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15769223', '12070297', '11884537', '13708383', '14492530']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7660802755865882
- 35 USC 102 Novelty (BERT): 0.5025708970171884
- Combined Prediction Score: 0.7397293377296482
- Mean Citation Score: 196.493056
- Max Citation Score: 202.77733
- Similarity Product: 125.50618997803868

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test